Viewing Study NCT01765803


Ignite Creation Date: 2025-12-24 @ 7:48 PM
Ignite Modification Date: 2026-03-13 @ 7:01 AM
Study NCT ID: NCT01765803
Status: TERMINATED
Last Update Posted: 2016-04-14
First Post: 2013-01-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Feasibility of Thioridazine as a Mobilizing Agent for CD34+ Hematopoietic Progenitor Cells
Sponsor: New Mexico Cancer Research Alliance
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: INST 1208
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None UNKNOWN View